Physician
Baton Rouge General Medical Center
Baton Rouge General Medical Center was paid $8.15M by Medicaid between Jun 2020 and Dec 2024, across 51 billing codes. Its largest line is 99285, emergency room visit (most serious) — 48% of everything it billed.
33Billing provider infoBATON ROUGE GENERAL MEDICAL CENTER
BATON ROUGE, LA 70806
BATON ROUGE, LA 70806
33aNPI1619504016assigned 03/25/2020
33bProvider typeEmergency Medicine Physician
28Total paid$8.15M
24GClaims104,149
24DCodes billed51
24AFirst – last monthJun 2020 – Dec 2024
Compared with peers
Next to other Emergency Medicine Physician providers in Louisiana
Rank by total paid#9 of 101
Median peer was paid$227K
This provider vs. median36×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official JOHNSON, KENDALL controls 19+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 6,941 | $286K | |
| 2021 | 18,438 | $949K | |
| 2022 | 22,913 | $1.58M | |
| 2023 | 33,923 | $3.07M | |
| 2024incomplete | 21,934 | $2.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 48% | 10,131 | 8,476 | $3.90M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 10,319 | 9,011 | $1.76M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.7% | 3,114 | 2,688 | $707K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.0% | 3,485 | 3,169 | $411K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.7% | 3,550 | 3,004 | $217K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.1% | 3,836 | 2,848 | $171K |
| G0378 | Hospital observation service, per hour | 1.4% | 859 | 480 | $117K |
| 80053 | Comprehensive metabolic panel | 1.2% | 15,763 | 13,310 | $101K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.2% | 1,858 | 1,203 | $101K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.2% | 2,601 | 2,241 | $100K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 3,605 | 2,286 | $93K |
| 71045 | Radiologic examination, chest; single view | 1.1% | 1,956 | 1,696 | $93K |
39 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 16,664 | $74K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,985 | $50K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 625 | $43K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 656 | $30K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 97 | $23K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,397 | $23K |
| 84484 | <1% | 1,905 | $15K | |
| 86803 | <1% | 1,535 | $14K | |
| 84703 | <1% | 2,381 | $14K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 475 | $11K |
| 81001 | <1% | 5,802 | $10K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 167 | $10K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 140 | $9K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 170 | $9K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,743 | $9K |
| 87400 | <1% | 513 | $6K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 880 | $5K |
| 82077 | <1% | 628 | $5K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 457 | $3K |
| 83690 | <1% | 533 | $3K | |
| 85730 | <1% | 545 | $2K | |
| 85610 | <1% | 650 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 111 | $1K |
| 83735 | <1% | 397 | $1K | |
| 82550 | <1% | 297 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 223 | $1K |
| 83880 | <1% | 62 | $1K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 173 | $972.25 |
| 36415 | Collection of venous blood by venipuncture | <1% | 519 | $934.33 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 329 | $756.53 |
| J1815 | Injection, insulin, per 5 units | <1% | 22 | $538.05 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 139 | $450.60 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 13 | $367.40 |
| 83605 | <1% | 51 | $347.10 | |
| 81003 | <1% | 174 | $242.12 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 45 | $178.31 |
| 85027 | <1% | 23 | $97.05 | |
| J3490 | Unclassified drugs | 0% | 519 | $0.00 |
| 00000 | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOHNSON, KENDALL (CFO)
Parent organizationBATON ROUGE GENERAL MEDICAL CENTER
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.